Galectin-1 regulates initial axonal growth in peripheral nerves after axotomy

Area of Science:

• Neuroscience
• Cell Biology
• Regenerative Medicine

Background:

• Axonal regeneration following peripheral nerve injury is crucial for functional recovery.
• The precise molecular signals initiating axon outgrowth after axotomy remain incompletely understood.

Purpose of the Study:

• To identify factors that promote initial axon and support cell outgrowth during nerve regeneration.
• To investigate the role of galectin-1 in peripheral nerve repair.

Main Methods:

• Development of an in vitro nerve regeneration model using COS1 cell-secreted factors.
• Identification of galectin-1 as the active regenerative factor.
• In vivo studies using rat and mouse models of peripheral nerve injury (transection, crush/freeze).
• Assessment of galectin-1's effect using recombinant human galectin-1 (rhGAL-1) and anti-rhGAL-1 antibodies.

Main Results:

• A factor secreted by COS1 cells was identified as galectin-1, significantly enhancing axonal regeneration.
• Low concentrations of rhGAL-1 (50 pg/ml) promoted axon and Schwann cell migration in vitro and in vivo.
• Application of anti-rhGAL-1 antibodies inhibited nerve regeneration both in vitro and in vivo.
• Galectin-1 expression was confirmed in regenerating sciatic nerves and neurons.

Conclusions:

• Galectin-1 plays a critical role in the initial stages of peripheral nerve repair after axotomy.
• The high activity of galectin-1 under nonreducing conditions suggests a cytokine-like function rather than a lectin function.
• Galectin-1 is a potential therapeutic target for enhancing nerve regeneration.